Supreme Court of the United States
Pharmaceutical Research and Manufacturers of America v. Walsh
May 19, 2003538 U.S. 644
Summary
Justice Stevens announced the judgment and delivered the opinion joined by Justices Souter, Ginsburg, and Breyer in part. The Court held that the District Court abused its discretion in entering a preliminary injunction because the petitioner had not carried its burden of showing a probability of success on the merits. Justices Thomas, Breyer, and Scalia concurred in the judgment. Justice O'Connor concurred in part and dissented in part. The opinion does not decide the ultimate validity of the Maine Rx Program.